SLU-PP-332 (related non-peptide)
An experimental small-molecule ERR agonist, not a peptide.
Investigational / no FDA-approved-treatment claim
An experimental small-molecule ERR agonist, not a peptide.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Purported uses, not established benefits
Proponents call SLU-PP-332 an exercise mimetic and claim metabolic or fat-loss effects.
The cited metabolic-syndrome work is in mice. An exercise-response pathway or animal weight change does not establish human fitness or weight-loss benefit.
Evidence and source limits
The source linked here describes research or investigational use. It does not establish an FDA-approved indication for this compound or for a research-chemical product. A claimed use is not an established benefit.
Product identity, purity, route, safety and suitability remain separate questions. Research-purpose-only labeling does not authorize human use. This note provides no dosing, preparation or purchase guidance.
Original source: SLU-PP-332 (related non-peptide) ↗
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.